Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 21589655)

1.

Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expression.

Browne AW, Leddon JL, Currier MA, Williams JP, Frischer JS, Collins MH, Ahn CH, Cripe TP.

PLoS One. 2011 May 11;6(5):e19530. doi: 10.1371/journal.pone.0019530.

2.

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.

Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC.

Prostate Cancer Prostatic Dis. 2002;5(4):316-25.

3.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

4.

Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.

Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.

Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14.

PMID:
19604626
5.

Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy.

Han ZQ, Assenberg M, Liu BL, Wang YB, Simpson G, Thomas S, Coffin RS.

J Gene Med. 2007 Feb;9(2):99-106.

PMID:
17256802
6.

VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.

Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.

Gene Ther. 2006 Oct;13(20):1457-70. Epub 2006 May 25.

PMID:
16724095
7.

Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.

Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.

Cancer Res. 2001 Dec 15;61(24):8743-50.

9.
10.

Gene delivery using herpes simplex virus vectors.

Burton EA, Fink DJ, Glorioso JC.

DNA Cell Biol. 2002 Dec;21(12):915-36. Review.

PMID:
12573050
11.

Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.

Adachi Y, Matsubara S, Muramatsu T, Curiel DT, Reynolds PN.

J Pediatr Surg. 2002 Apr;37(4):588-92.

PMID:
11912516
12.

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.

Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL.

Cancer Res. 2003 Apr 1;63(7):1490-9.

15.
17.

Oncolytic herpes simplex virus treatment of metastatic breast cancer.

Wang J, Hu P, Zeng M, Rabkin SD, Liu R.

Int J Oncol. 2012 Mar;40(3):757-63. doi: 10.3892/ijo.2011.1266. Epub 2011 Nov 21.

PMID:
22108767
18.

Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.

Liu R, Martuza RL, Rabkin SD.

Gene Ther. 2005 Apr;12(8):647-54.

PMID:
15647762
19.

Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.

Yamamura H, Hashio M, Noguchi M, Sugenoya Y, Osakada M, Hirano N, Sasaki Y, Yoden T, Awata N, Araki N, Tatsuta M, Miyatake SI, Takahashi K.

Cancer Res. 2001 May 15;61(10):3969-77.

20.

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.

J Gene Med. 2004 Mar;6(3):288-99.

PMID:
15026990
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk